AMR Action Fund CEO Henry Skinner and Bettina Hamelin, president of Innovative Medicines Canada, co-authored an op-ed for The Hill Times calling on Canada to use its upcoming G7 presidency to enact a pull incentive and encourage other G7 countries to act on AMR.
"Canada should use its presidency to action its Pan-Canadian Action Plan on Antimicrobial Resistance, and move the world from discourse to action by launching a national pull incentive designed to fit within our federal-provincial-territorial health system. This would be a concrete step that benefits citizens suffering from intractable infections while supporting our domestic biotech sector and leading the world toward global reforms," they write.
Read the full op-ed here.
